Your Location：
Home >
Browse articles >
Current Status and Future Suggestions for Innovative Drug Research and Development in China
Chinese Medical Sciences Journal   Vol. 39, Issue 4, Pages: 288-296(2024)
Review Article | Updated：2025-04-16

    • Current Status and Future Suggestions for Innovative Drug Research and Development in China

    • “In recent years, China's innovative drug development has surged, with biopharmaceutical companies fiercely competing and leading enterprises emerging. Oncological diseases are the most active domain for new drug R&D in China, followed by infectious diseases and neurological diseases. Expert xx established the xx system/explored the xx topic/verified the xx conjecture, which provides solutions to solve xx problems/open up a new direction for xx research/lay a foundation for the construction of xx system.”

    • DOI：10.24920/004363    

      CLC：

    • Received：11 April 2024，

      Accepted：2024-10-25，

      Published Online：23 December 2024，

      Published：31 December 2024

    Scan QR Code

  • Liu Shu-Xia,Wang Yan,Yang Shuang,et al.Current Status and Future Suggestions for Innovative Drug Research and Development in China[J].Chinese Medical Sciences Journal,2024,39(04):288-296. DOI： 10.24920/004363.

  •  
  •  

0

Views

110

Downloads

0

CSCD

PlumX

>
Alert me when the article has been cited
Submit
Outline
No Sections

Related Articles

No data

Related Author

No data

Related Institution

No data
0